AzTrials
AzTrials

Motor ImageryNCT07347756

The Effect of Gait Imagery on the Muscular Activity of Lower Limbs and Lower Body Kinematics in Stroke Survivors

A study testing gait imagery in people with Motor Imagery and Stroke, run by Hana Haltmar at 2 sites in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the effect of normal gait imagery and gait on a line imagery on lower limb muscle activity and lower body kinematics in stroke survivors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Motor Imagery, Stroke
What is being tested?
gait imagery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesCzechia
Study dates
1 Mar 2021to 1 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subacute stage (1 week - 2 months after the onset of the attack) after primary attack of stroke
  • Ischemic origin of stroke
  • Good cognitive level to understand the study
  • Minimum age of 18 years
  • Clinically manifested hemiparetic gait with ability to perform independent walking for at least five minutes
  • Mild motor deficit with ability to maintain standing without any support
  • Ability to walk independently without any manual assistance of another person (≥ 3/5 points according to the Functional Ambulation Categories)
  • Good level (≥ 4/7 points) of kinesthetic and visual MI according to the Czech version of the MIQ-RS questionnaire

Who cannot join

  • Present impairments in communication and cognition
  • An additional neurological, internal, psychological or psychiatric disorder or severe musculoskeletal disorder that may affect the ambulation
  • Previous experience with MI
  • Pain during the measurement

Trial locations and contacts

2 sites in 1 country.

Czechia2 sites
  • Palacky University

    Olomouc, 77111

  • University Hospital Olomouc

    Olomouc, 77900

Other trials in Czechia

About this study

Official title: The Effect of Gait Imagery on the Muscular Activity of Lower Limbs and Lower Body Kinematics in Subacute Stroke Survivors

The aim of the study is to evaluate the effect of normal gait imagery and gait on a line imagery on lower limb muscle activity and lower body kinematics in stroke survivors.

Read the detailed description

Gait imagery is a cognitive process involving the mental simulation of a gait that is not actually performed. According to current studies, gait imagery has very similar neural activity to that observed in real gait. This activity can be observed not only at the central level, but also at the end effector - the muscle - using surface electromyography. Across studies, muscle activity and kinematics are evaluated in particular when imagining analytical movements of the upper or lower limbs, but complex and posturally more demanding movements (in our case, gait and its modification - gait on a line) are studied to a lesser extent. Independent walking and the ability to adapt it to the terrain is important in rehabilitation therapy for patients with limited mobility. These individuals include, among others, a stroke survivors. The aim of the study is therefore to evaluate the effect of normal gait imagery and gait on a line imagery on lower limb muscle activity and lower body kinematics in these individuals.

Being tested
gait imagery
Keywords
motor imagery, gait, surface electromyography, angular velocity, acceleration, stroke
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gait imageryBehavioural

    The initial position, which is identical for all measured tasks, consisted of an upright bipedal stance in front of an unobtrusive white screen with feet at pelvic width, upper limbs held loosely along the body, eyes open and facing forward. During the rest task, non-motor imagery task, participants are instructed to sing the song "Happy Birthday" in their minds.

    NGI before the real execution of normal gait and GLI before the real execution of gait on the line are tasks associated with the imagery of normal gait or tandem gait on the line. Participants first observed a 5 m section of the corridor for NGI, or a line located in the middle of the same corridor for GLI.

    The last tasks, NGI after the real execution of normal gait and GLI after the real execution of gait on the line, differed from above mentioned tasks in the immediate real experience of normal gait or gait on the line.

Study groups in NCT07347756
Study groupRoleWhat they receive
InterventionExperimentalAll individuals will be instructed to realize normal gait imagery (NGI) and gait on the line imagery (GLI) modalities in a single experimental session. The order of imagining these two gait modalities was randomized and both modalities consisted of these tasks: rest (non-imagery task), NGI/GLI before and after the real execution of normal gait/tandem gait on the line. The order of the tasks was not randomized. Individuals are also asked about the ease/difficulty of imagining both NGI/GLI before and after the real execution of gait tasks using a five-point scale. Each task is measured once for 30 s with respect to sustained attention and possible onset of fatigue.
Receives: Behavioral: gait imagery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective measurement of muscle activity

    Muscle activity [V] will be measured by surface electromyography during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).

    Measured: Day 1

  2. Objective measurement of lower body kinematics 1

    Lower body kinematics will be measured by gyroscope [deg/s] during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).

    Measured: Day 1

  3. Objective measurement of lower body kinematics 2

    Lower body kinematics will also be measured by accelerometer [g] during all tasks (rest and gait imagery before/after real gait execution) across both gait imagery modalities (normal gait imagery and gait on the line imagery).

    Measured: Day 1

Secondary outcomes (1)
  1. Questionnaire - Evaluation of gait imagery

    Individuals will be asked about ease/difficulty of imagining both normaI gait imagery/gait on the line imagery before and after the real execution of gait tasks using a five-point scale (maximum value - 5 points [easy] to minimum value - 1 point [difficult]).

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2026
  2. Study start1 Mar 2021
  3. Primary completion1 Jan 2022
  4. Study completion1 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07347756
Sponsor's protocol ID
IGA_FTK_2021_014
Other IDs
13/2021
Status last verified
Dec 2025
First submitted
7 Dec 2025
Last updated
21 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Haltmar H., Janura M., Haltmar M., & Elfmark M. (2024).The effect of gait imagery and its more demanding variant on muscle activity in stroke survivors. Rehabilitace a fyzikální lékařství, 31(3), 116-125. doi: 10.48095/ccrhfl2024116.

Questions about this trial

What is this clinical trial studying?

A study testing gait imagery in people with Motor Imagery and Stroke, run by Hana Haltmar at 2 sites in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective measurement of muscle activity (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07347756, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in